简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2012-11-21 15:50 Nanobiotix: Phase I Independent Data Monitoring Committee Confirms Good Safety of NBTXR3 in the First Group of Patients with Advanced Soft Tissue Sarcoma
2012-11-20 13:36 Platelet Reactivity Testing Recommended in New 2012 Surgical Guidelines
2012-11-16 18:13 Cook Medical’s Zilver® PTX® Earns FDA Approval As First Drug-Eluting Stent in U.S. to Treat Peripheral Arterial Disease
2012-11-15 12:08 Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of ACR20 in the First Phase III Study (PALACE-1) in Patients with Psoriatic Arthritis
2012-11-14 16:58 Covidien Reports Fourth-Quarter and Fiscal 2012 Results
2012-11-14 14:26 Defibtech Signs Agreement to be Acquired by Nihon Kohden Corporation
2012-11-14 11:46 Study to Evaluate Safety and Efficacy of Fuzheng Huayu as an Anti-Fibrotic Treatment in U.S. Hepatitis C Patients Nears Completion
2012-11-13 23:30 TEMPTIME CORPORATION Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development
2012-11-12 15:43 ABRAXANE® Demonstrates Statistically Significant Improvement in Overall Survival for Patients with Advanced Pancreatic Cancer in Phase III Study
2012-11-09 15:23 KCI Sells Therapeutic Support Systems™ Business to Getinge AB
2012-11-08 10:08 Cirrus HD-OCT Record Number of 10,000 Installations and Prestigious Award for OCT Inventors
2012-11-07 14:33 Taiho Pharmaceutical Unveils Data on Eight Novel Anticancer Compounds in Bid to Become a New Global Leader in Oncology
2012-11-06 17:41 ICON Launches New Functional Service Provision (FSP) Strategy
2012-11-06 15:05 Quintiles Study Confirms Validity of Data from Patients Recruited Over the Internet
2012-11-05 21:15 PerkinElmer Launches New Epigenetic Cellular Detection Research Kits at its Revolutionaries for Global Health Summit
2012-11-04 03:30 Otsuka's Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD), Tolvaptan, Meets Primary Endpoint in a Phase III Clinical Trial
2012-11-02 14:16 TTP054, a Novel, Orally Active Drug for Glucose Control, Progresses towards Completion of a Phase 2 Proof-of-Concept Clinical Trial in Type 2 Diabetics
2012-10-30 16:05 Novel, Oral Drug TTP488 Shows Promise for Disease Modification in Alzheimer’s Patients
2012-10-29 16:45 Cegedim Relationship Management Mobile Intelligence Features Full Compatibility with Windows 8
2012-10-26 14:29 8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

Business Wire Weibo

Press Releases

Latest Releases